![](/img/cover-not-exists.png)
Lamivudine therapy in patients undergoing liver transplantation for hepatitis b virus precore mutant–associated infection: High resistance rates in treatment of recurrence but universal prevention if used as prophylaxis with very low dose hepatitis B immune globulin
Geoffrey W. McCaughan, Jenean Spencer, David Koorey, Scott Bowden, Angeline Bartholomeusz, Margaret Littlejohn, Deborah Verran, Albert K.K. Chui, A.G. Ross Sheil, Robert M. Jones, Stephen A. LocarniniVolume:
5
Year:
1999
Language:
english
Pages:
8
DOI:
10.1002/lt.500050601
File:
PDF, 75 KB
english, 1999